Teng Lin, Xiao Yongchuan, Zhong Gang
Department of Orthopedics, the First People's Hospital in Shuangliu District/West China Airport Hospital, Sichuan University, Chengdu Sichuan, 610200, P.R.China.
Department of Orthopedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021 Mar 15;35(3):312-317. doi: 10.7507/1002-1892.202010011.
To investigate the occurrence, treatment, and effectiveness of peri-implant refracture after intramedullary nail fixation for intertrochanteric fractures.
The clinical data of 16 patients with peri-implant refracture after intramedullary nail fixation for intertrochanteric fractures who met the inclusion criteria between April 2014 and November 2019 were retrospectively analyzed. There were 7 males and 9 females with an average age of 78.4 years (range, 65-93 years). The 14 cases of initial intertrochanteric fractures were classified according to the classification of AO/Orthopaedic Trauma Association (AO/OTA): 5 cases of type A1, 7 cases of type A2, and 2 cases of type A3; the other 2 cases were intertrochanteric combined with subtrochanteric fractures (Seinsheimer type Ⅴ). According to the classification of peri-implant refracture which was proposed by Chan ., there were 10 cases of type 1 (6 cases of type 1A, 3 cases of type 1B, 1 case of type 1C) and 6 cases of type 2 (4 cases of type 2A and 2 cases of type 2B). The average interval between refracture and initial surgery was 14.6 months (range, 1-52 months). The incidence of peri-implant refracture in short nail group (the length of intramedullary nail used in initial surgery≤240 mm) was 1.92% (11/573), while the incidence of long nail group (the length of intramedullary nail used in initial surgery≥340 mm) was 1.66% (5/301), showing no significant difference between the two groups ( =0.073, =0.786). The peri-implant refractures were revised with extended intramedullary nail (5 cases) or fixed with additional limited invasive stabilization system (11 cases).
The average operation time was 115.8 minutes (range, 78-168 minutes) and the average intraoperative blood loss was 283.1 mL (range, 120-500 mL). One patient died of myocardial infarction at 3 months after operation, and the other 15 patients were followed up 9-46 months (mean, 16.8 months). The peri-implant refractures healed at 14-20 weeks (mean, 16.4 weeks) after operation. There was no complications such as incision infection, nonunion, internal fixator loosening and rupture, screw cutting-out, and the second refracture during the follow-up. At last follow-up, all injured limbs regained walking function, and the Hospital for Special Surgery (HSS) score was 56-92 (mean, 80.2). The results were classified as excellent in 2 cases, good in 10, fair in 2, and poor in 1, with the excellent and good rate of 80%.
Stress concentration at the tip of initial intramedullary nail and distal interlocking screw aera is the main cause of peri-implant refracture after intramedullary nail fixation for intertrochanteric fractures. Revision with extended intramedullary nail or fixation with limited invasive stabilization system according to the length of initial intramedullary nail and the type of refracture can get satisfactory effectiveness.
探讨股骨转子间骨折髓内钉固定术后植入物周围再骨折的发生情况、治疗方法及疗效。
回顾性分析2014年4月至2019年11月期间符合纳入标准的16例股骨转子间骨折髓内钉固定术后植入物周围再骨折患者的临床资料。其中男性7例,女性9例,平均年龄78.4岁(范围65 - 93岁)。14例初次股骨转子间骨折按AO/骨科创伤协会(AO/OTA)分类:A1型5例,A2型7例,A3型2例;另外2例为转子间合并转子下骨折(SeinsheimerⅤ型)。根据Chan等提出的植入物周围再骨折分类,1型10例(1A 型6例,1B型3例,1C型1例),2型6例(2A型4例,2B型2例)。再骨折与初次手术的平均间隔时间为14.6个月(范围1 - 52个月)。短钉组(初次手术使用的髓内钉长度≤240 mm)植入物周围再骨折发生率为1.92%(11/573),长钉组(初次手术使用的髓内钉长度≥340 mm)为1.66%(5/301),两组差异无统计学意义( =0.073, =0.786)。植入物周围再骨折采用加长髓内钉翻修5例,或附加有限切开稳定系统固定11例。
平均手术时间115.8分钟(范围78 - 168分钟),平均术中出血量283.1 mL(范围120 - 500 mL)。1例患者术后3个月死于心肌梗死,其余15例患者随访9 - 46个月(平均16.8个月)。植入物周围再骨折术后14 - 20周(平均16.4周)愈合。随访期间无切口感染、骨不连、内固定松动断裂、螺钉切割穿出及二次骨折等并发症。末次随访时,所有伤肢均恢复行走功能,美国特种外科医院(HSS)评分56 - 92分(平均80.2分)。结果评定为优2例,良10例,可2例,差1例,优良率80%。
初次髓内钉尖端及远端锁钉区域应力集中是股骨转子间骨折髓内钉固定术后植入物周围再骨折的主要原因。根据初次髓内钉长度及再骨折类型采用加长髓内钉翻修或有限切开稳定系统固定可获得满意疗效。